Catalyst Pharmaceuticals, Inc.
Posted on: June 28, 2021
By: Kim Berlowitz
With: Comments Off on Catalyst Pharmaceuticals, Inc.
MTS served as the exclusive financial advisor to Catalyst Pharmaceuticals on its outlicensing of Firdapse in Japan to DyDo Pharma